Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026)
Alcon's (ALC) quarterly Net Income towards Common Stockholders came in at $22.1 billion in Q1 2026, up 10099.08% quarter-over-quarter from $217.0 million in Q4 2025.
Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Alcon's Net Income towards Common Stockholders history runs 11 years deep, the most recent figure standing at $22.1 billion for Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders changed N/A year-over-year to $22.1 billion in Q1 2026; TTM through Mar 2026 was $66.5 billion, a 8542.73% increase from a year earlier, with the FY2025 full-year figure at $22.0 billion, up 2.23% from the prior year.
- Net Income towards Common Stockholders grew to $22.1 billion in Q1 2026 per ALC's latest filing, from $217.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $22.1 billion in Q1 2026 and bottomed at -$31.0 million in Q4 2022.
- The 5-year median for Net Income towards Common Stockholders is $220.0 million (2024), against an average of $4.3 billion.
- Across the five-year window, Net Income towards Common Stockholders sank 121.99% in 2022 and surged 9816.59% in 2025, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$31.0 million in 2022, then jumped by 641.94% to $168.0 million in 2023, then soared by 69.05% to $284.0 million in 2024, then retreated by 23.59% to $217.0 million in 2025, then surged by 10099.08% to $22.1 billion in 2026.
- Per Business Quant, the three latest ALC Net Income towards Common Stockholders figures stand at $22.1 billion (Q1 2026), $217.0 million (Q4 2025), and $22.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 33,163,703.85 Bn | 33,163,702.19 Bn | 1.53 Bn | 22.13 Bn |
| 2 | Intuitive Surgical | 119.67 Bn | 114.45 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 43.92 Bn | 43.11 Bn | 2.15 Bn | -274.00 Mn |
| 4 | Medline | 31.71 Bn | 29.47 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 28.46 Bn | 26.80 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.80 Bn | 23.28 Bn | 296.40 Mn | 135.40 Mn |
| 7 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.63 Bn | 13.06 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 11.94 Bn | 10.88 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 11.56 Bn | 9.54 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.13 Bn |
| Dec 31, 2025 | 217.00 Mn |
| Sep 30, 2025 | 22.09 Bn |
| Jun 30, 2025 | 22.11 Bn |
| Dec 31, 2024 | 284.00 Mn |
| Sep 30, 2024 | 263.00 Mn |
| Jun 30, 2024 | 223.00 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | 168.00 Mn |
| Sep 30, 2023 | 238.00 Mn |
| Jun 30, 2023 | 213.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | -31.00 Mn |
| Sep 30, 2022 | 147.00 Mn |
| Jun 30, 2022 | 147.00 Mn |
| Mar 31, 2022 | 200.00 Mn |
| Dec 31, 2021 | 141.00 Mn |
| Sep 30, 2021 | -23.00 Mn |
| Jun 30, 2021 | 191.00 Mn |
| Mar 31, 2021 | 109.00 Mn |